ANISSA MORRIS: Open Payments
NPI 1063120871 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 15 payments from 9 companies in 2025. Trend: 2023 $335 · 2024 $372 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| MEDICOMP INC | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VERQUVO, JARDIANCE, LEQVIO, FARXIGA, Exparel, TELEPATCH CARDIAC MONITOR, CAMZYOS, Kerendia.
Industry payments across TX — which companies pay providers there.
